Package 0069-6001-21

{"route": ["INTRAMUSCULAR", "INTRAVENOUS"], "spl_id": "c2767f24-e5ac-4d94-8bff-faf0a6eaf7c4", "openfda": {"unii": ["7VLR55452Z"], "rxcui": ["1670195", "1670197", "1670200", "1670201"], "spl_set_id": ["d4c36fad-0ba2-4cd4-9c5e-dcf843f38a5a"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "10 VIAL in 1 PACKAGE (0069-6001-21)  / 10 mL in 1 VIAL (0069-6001-10)", "package_ndc": "0069-6001-21", "marketing_start_date": "20131028"}, {"sample": false, "description": "25 VIAL in 1 CARTON (0069-6001-25)  / 2 mL in 1 VIAL (0069-6001-02)", "package_ndc": "0069-6001-25", "marketing_start_date": "20131028"}], "brand_name": "CEREBYX", "product_id": "0069-6001_c2767f24-e5ac-4d94-8bff-faf0a6eaf7c4", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0069-6001", "generic_name": "Fosphenytoin Sodium", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "CEREBYX", "active_ingredients": [{"name": "FOSPHENYTOIN SODIUM", "strength": "50 mg/mL"}], "application_number": "NDA020450", "marketing_category": "NDA", "marketing_start_date": "20131028", "listing_expiration_date": "20261231"}